North America Molecular Diagnostics Market (2024 - 2030) Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Others), By Test Location, By Technology (PCR, ISH, INAAT, Sequencing), By Application, By Country, And Segment Forecasts

Market Segmentation

• North America Molecular Diagnostics Market Product Outlook (USD Million, 2018 - 2030)
  • Instruments
  • Reagents
  • Others
• North America Molecular Diagnostics Market Test Location Outlook (USD Million, 2018 - 2030)
  • Point-of-Care
  • Self-test or Over the Counter
  • Central Laboratories
• North America Molecular Diagnostics Market Technology Outlook (USD Million, 2018 - 2030)
  • Polymerase Chain Reaction (PCR)
    • PCR, by Type
      • Multiplex PCR
      • Other PCR
    • PCR, by Procedure
      • Nucleic Acid Extraction
      • Others
    • PCR, by Product
      • Instruments
      • Reagents
      • Others
  • In Situ Hybridization
    • Instruments
    • Reagents
    • Others
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Instruments
    • Reagents
    • Others
  • Chips and Microarrays
    • Instruments
    • Reagents
    • Others
  • Mass spectroscopy
    • Instruments
    • Reagents
    • Others
  • Sequencing
    • Instruments
    • Reagents
    • Others
  • Transcription Mediated Amplification (TMA)
    • Instruments
    • Reagents
    • Others
  • Others
    • Instruments
    • Reagents
    • Others
• North America Molecular Diagnostics Market Application Outlook (USD Million, 2018 - 2030)
  • Oncology
    • Breast Cancer
    • Prostate Cancer
    • Colorectal Cancer
    • Cervical Cancer
    • Kidney Cancer
    • Liver Cancer
    • Blood Cancer
    • Lung Cancer
    • Other Cancer
  • Pharmacogenomics
  • Infectious Diseases
    • Methicillin-resistant Staphylococcus Aureus (MRSA)
    • Clostridium Difficile
    • Vancomycin-resistant Enterococci (VRE)
    • Carbapenem-resistant Bacteria
    • Flu
    • Respiratory Syncytial Virus (RSV)
    • Candida
    • Tuberculosis and Drug-resistant TBA
    • Meningitis
    • Gastrointestinal Panel Testing
    • Chlamydia
    • Gonorrhea
    • HIV
    • Hepatitis C
    • Hepatitis B
    • Other Infectious Disease
  • Genetic Testing
    • Newborn Screening
    • Predictive and Presymptomatic Testing
    • Other Genetic Testing
  • Neurological Disease
  • Cardiovascular Disease
  • Microbiology
  • Others
• North America Molecular Diagnostics Market Regional Outlook (USD Million, 2018 - 2030)
  • U.S.
    • U.S. Diagnostics Market Product Outlook (USD Million, 2018 - 2030)
      • Instruments
      • Reagents
      • Others
    • U.S. Molecular Diagnostics Market Test Location Outlook (USD Million, 2018 - 2030)
      • Point-of-Care
      • Self-test or Over the Counter
      • Central Laboratories
    • U.S. Molecular Diagnostics Market Technology Outlook (USD Million, 2018 - 2030)
      • Polymerase Chain Reaction (PCR)
        • PCR, by Type
          • Multiplex PCR
          • Other PCR
        • PCR, by Procedure
          • Nucleic Acid Extraction
          • Others
        • PCR, by Product
          • Instruments
          • Reagents
          • Others
      • In Situ Hybridization
        • Instruments
        • Reagents
        • Others
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
        • Instruments
        • Reagents
        • Others
      • Chips and Microarrays
        • Instruments
        • Reagents
        • Others
      • Mass spectroscopy
        • Instruments
        • Reagents
        • Others
      • Sequencing
        • Instruments
        • Reagents
        • Others
      • Transcription Mediated Amplification (TMA)
        • Instruments
        • Reagents
        • Others
      • Others
        • Instruments
        • Reagents
        • Others
    • U.S.​​​​​​​ Molecular Diagnostics Market Application Outlook (USD Million, 2018 - 2030)
      • Oncology
        • Breast Cancer
        • Prostate Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Kidney Cancer
        • Liver Cancer
        • Blood Cancer
        • Lung Cancer
        • Other Cancer
      • Pharmacogenomics
      • Infectious Diseases
        • Methicillin-resistant Staphylococcus Aureus (MRSA)
        • Clostridium Difficile
        • Vancomycin-resistant Enterococci (VRE)
        • Carbapenem-resistant Bacteria
        • Flu
        • Respiratory Syncytial Virus (RSV)
        • Candida
        • Tuberculosis and Drug-resistant TBA
        • Meningitis
        • Gastrointestinal Panel Testing
        • Chlamydia
        • Gonorrhea
        • HIV
        • Hepatitis C
        • Hepatitis B
        • Other Infectious Disease
      • Genetic Testing
        • Newborn Screening
        • Predictive and Presymptomatic Testing
        • Other Genetic Testing
      • Neurological Disease
      • Cardiovascular Disease
      • Microbiology
      • Others
  • Canada
    • Canada Diagnostics Market Product Outlook (USD Million, 2018 - 2030)
      • Instruments
      • Reagents
      • Others
    • Canada Molecular Diagnostics Market Test Location Outlook (USD Million, 2018 - 2030)
      • Point-of-Care
      • Self-test or Over the Counter
      • Central Laboratories
    • Canada Molecular Diagnostics Market Technology Outlook (USD Million, 2018 - 2030)
      • Polymerase Chain Reaction (PCR)
        • PCR, by Type
          • Multiplex PCR
          • Other PCR
        • PCR, by Procedure
          • Nucleic Acid Extraction
          • Others
        • PCR, by Product
          • Instruments
          • Reagents
          • Others
      • In Situ Hybridization
        • Instruments
        • Reagents
        • Others
      • Isothermal Nucleic Acid Amplification Technology (INAAT)
        • Instruments
        • Reagents
        • Others
      • Chips and Microarrays
        • Instruments
        • Reagents
        • Others
      • Mass spectroscopy
        • Instruments
        • Reagents
        • Others
      • Sequencing
        • Instruments
        • Reagents
        • Others
      • Transcription Mediated Amplification (TMA)
        • Instruments
        • Reagents
        • Others
      • Others
        • Instruments
        • Reagents
        • Others
    • Canada​​​​​​​ Molecular Diagnostics Market Application Outlook (USD Million, 2018 - 2030)
      • Oncology
        • Breast Cancer
        • Prostate Cancer
        • Colorectal Cancer
        • Cervical Cancer
        • Kidney Cancer
        • Liver Cancer
        • Blood Cancer
        • Lung Cancer
        • Other Cancer
      • Pharmacogenomics
      • Infectious Diseases
        • Methicillin-resistant Staphylococcus Aureus (MRSA)
        • Clostridium Difficile
        • Vancomycin-resistant Enterococci (VRE)
        • Carbapenem-resistant Bacteria
        • Flu
        • Respiratory Syncytial Virus (RSV)
        • Candida
        • Tuberculosis and Drug-resistant TBA
        • Meningitis
        • Gastrointestinal Panel Testing
        • Chlamydia
        • Gonorrhea
        • HIV
        • Hepatitis C
        • Hepatitis B
        • Other Infectious Disease
      • Genetic Testing
        • Newborn Screening
        • Predictive and Presymptomatic Testing
        • Other Genetic Testing
      • Neurological Disease
      • Cardiovascular Disease
      • Microbiology
      • Others

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2018 to 2030
• Market estimates and forecast for product segments up to 2030
• Regional market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Regional market size and forecast for application segments up to 2030
• Company financial performance